Moleculera Biosciences
PrivateLast Round
Series A
May 21, 2025
Total Funding Raised
$4.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Moleculera Biosciences operates in Healthcare & Life Sciences and is based in Oklahoma City, Oklahoma. Its latest recorded funding round was a Grant round in October 2024.
Moleculera Biosciences is a laboratory services (healthcare) company that provides personalized clinical testing services intended to offer molecular diagnostic testing for autoimmune neuroimmunology.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, Clinical Trials, Medical AI
Business Model
B2B2C
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Moleculera Biosciences Comparables
Compare Moleculera Biosciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ZeiniX Life Sciences | 80% | |
| Mitogen Diagnostics | 77% | |
| GLX Analytix | 71% |
For institutional investors. Book with your work email.
Moleculera Biosciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 21, 2025 | ||||
| Grant | Oct 30, 2024 | ||||
| Grant | Jan 11, 2024 | ||||
| Grant | Jul 7, 2015 | ||||
| Seed | May 20, 2015 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Moleculera Biosciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| i2E | Seed |
| SeedStep Angels | Seed |
| Oklahoma Center for the Advancement of Science and Technology | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors grew 104% MoM, reaching 5.7K.
- Feb 27, 2025
Monthly visitors increased 47% MoM, reaching 15.7K.
For institutional investors. Book with your work email.
Moleculera Biosciences Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Moleculera Biosciences's valuation, stock price, and market status.
Is Moleculera Biosciences a public or private company?
Moleculera Biosciences is a private company.
What is the current stock price of Moleculera Biosciences?
Moleculera Biosciences is a private company, so its shares have no public market price. Caplight tracks Moleculera Biosciences's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Moleculera Biosciences worth (valuation)?
Valuation information for Moleculera Biosciences is not publicly available.
Can I buy Moleculera Biosciences stock?
Moleculera Biosciences shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Moleculera Biosciences's last funding round?
Moleculera Biosciences's most recent funding round was Series A on May 21, 2025.
Who are the main investors in Moleculera Biosciences?
Key investors in Moleculera Biosciences include i2E.
Will Moleculera Biosciences IPO soon?
No public IPO plans have been announced for Moleculera Biosciences.
How can I track Moleculera Biosciences secondary market activity?
Caplight tracks bids, offers, and trades in Moleculera Biosciences's shares on secondary markets.